Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Beijing Pharma to IPO in Hong Kong

publication date: Nov 23, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Beijing Pharmaceutical, a subsidiary of China Resources Medications Group, plans to list on the Hong Kong Stock Exchange, one more piece of evidence that Hong Kong is the exchange of choice for large China pharma IPOs. As yet, the size of the offering is not known. However, Beijing Pharma’s revenues are expected to hit 16 billion RMB ($2.4 billion) in 2010, up from 10 billion ($1.5 billion) in 2009. More details....



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors